Company news

Lifemd, Inc. (NASDAQ:LFMD) news

Every Lifemd, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Lifemd, Inc. stock analysis →

Press releases & updates

UPDATE - LifeMD Reports Second Quarter 2026 Results

August 5, 2026

LifeMD Reports Second Quarter 2026 Results

August 5, 2026

LifeMD to Report Second Quarter 2026 Financial Results on August 5

July 24, 2026

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

June 22, 2026

LifeMD Appoints Umesh Sripad as Chief Technology Officer

June 1, 2026

LifeMD to Participate in Upcoming Investor Conferences

May 15, 2026

LifeMD Reports First Quarter 2026 Results

May 6, 2026

LifeMD to Report First Quarter 2026 Financial Results on May 6

April 27, 2026

LifeMD(R) Now Offering Eli Lilly and Company's Foundayo (orforglipron), a New GLP-1 Pill for Weight Management

April 13, 2026

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

April 10, 2026

LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program

April 1, 2026

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

March 31, 2026

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

March 16, 2026

LifeMD Reports Fourth Quarter and Full Year 2025 Results

March 9, 2026

LifeMD to Participate in Two Investor Conferences During March

March 3, 2026

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

February 23, 2026

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

January 6, 2026

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

January 5, 2026

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

December 26, 2025

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026

November 24, 2025

LifeMD Reports Third Quarter 2025 Results

November 17, 2025

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

November 17, 2025

LifeMD to Participate in the BTIG Digital Health Forum

November 10, 2025

LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

November 5, 2025

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

November 4, 2025

LifeMD to Report Third Quarter 2025 Financial Results on November 6

October 23, 2025

LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program

October 22, 2025

Health-E Commerce® Expands Telehealth Weight Loss Options with MEDVi and Remedy Meds

October 21, 2025

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

September 30, 2025

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

September 25, 2025

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale

September 18, 2025

LifeMD to Participate in Three Investor Conferences During September

August 28, 2025

LifeMD Reports Second Quarter 2025 Results

August 5, 2025

LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference

August 4, 2025

LifeMD Names COO and Promotes Two Executives

July 31, 2025

LifeMD to Report Second Quarter 2025 Financial Results on August 5

July 29, 2025

LifeMD to Participate in Two Investor Conferences During June

June 9, 2025

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

May 22, 2025

LifeMD to Participate in Three Investor Conferences During May

May 12, 2025

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance

May 6, 2025

LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients

April 29, 2025

LifeMD to Report First Quarter 2025 Financial Results on May 6

April 28, 2025

LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market

April 28, 2025

LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs

April 17, 2025

LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference

March 31, 2025

LifeMD Reports Fourth Quarter 2024 Results

March 10, 2025

LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound

March 6, 2025

LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum

March 5, 2025

LifeMD to Report Fourth Quarter 2024 Financial Results on March 10

February 25, 2025

LifeMD® Announces Entry Into the Behavioral Health Market

February 24, 2025

Older →